RxDoctor Payments Data

Husam Hamed, MD

Family Medicine · Fairfield Township, OHNPI 1073550786

Payments from drug & device makers

$355in general payments, 2019–2025

Across 5 payments — averaging $71.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acadia Pharmaceuticals Inc$120
  • Amgen$85
  • Akcea Therapeutics, Inc.$72
  • AstraZeneca$52
  • Sunovion Pharmaceuticals Inc.$27

What the payments were for

  • Food & beverage$355100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$355 in reported general payments places this provider in the 45th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$185,869
Medicare patients
567
Services billed
1,649

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban430$181,840
XareltoRivaroxaban70$23,666
FarxigaDapagliflozin Propanediol79$22,959
TrulicityDulaglutide22$22,171
MyrbetriqMirabegron58$20,916
JardianceEmpagliflozin34$17,568
NuedextaDextromethorphan Hbr/Quinidine25$16,309
LinzessLinaclotide28$15,909
Atorvastatin Calcium890$12,166
TradjentaLinagliptin30$11,562
EntrestoSacubitril/Valsartan16$9,129
GemtesaVibegron36$8,730
FingolimodFingolimod Hcl12$8,352
CorlanorIvabradine Hcl28$8,328
Breo ElliptaFluticasone/Vilanterol19$8,226

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Brilinta$52$29,615108 claims
AmgenCorlanor$85$8,32828 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Fairfield Township

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →